ASCO 2026: Turn Oncology Data into Smarter Trial Strategy, Upcoming Webinar Hosted by Xtalks
In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient...
In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient...
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed...
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company...
NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical...
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.3 MILLION PRIVATE PLACEMENT Paris, July 1st, 2026, 8am...
SEATTLE, WA / ACCESS Newswire / June 30, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel...
HONG KONG and NEW YORK, June 30, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a leading AI-driven drug delivery innovation company,...
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 26, 2026 /PRNewswire/ -- The New York...
Cover Image Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program Santa Rosa, United States, June 25, 2026...
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over...
Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation...
Ranked second globally in 24-hour spot trading volume, Gate further extends market access and secondary liquidity for Enlivex’s primary digital...
Eligibility extends to patients with unresectable or metastatic synovial sarcoma who have received prior chemotherapy and meet HLA and MAGE-A4...
New leadership begins as the global allergy community advances the Vision Zero ambition of a future free from allergy and...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
Leading Pediatric Osteosarcoma Nonprofit to Present $400,000 to 5 Scientists During Annual Conference to Find Kinder Treatments for Patients BARNARD,...
NASHVILLE, Tenn., June 15, 2026 /PRNewswire/ -- Immorta Bio President Thomas Ichim and TAM Global's Chief Scientific Officer Francesco M....
Media ReleaseCOPENHAGEN, Denmark; June 13, 2026 Results from the Phase 2 EPCORE® DLBCL-3 trial show fixed-duration epcoritamab monotherapy demonstrated early...
Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of...